Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Capital Expenditures (2023 - 2026)

bioAffinity Technologies has reported Capital Expenditures over the past 4 years, most recently at $5663.0 for Q1 2026.

  • Quarterly Capital Expenditures fell 88.85% to $5663.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $15445.0 through Mar 2026, down 82.54% year-over-year, with the annual reading at $60568.0 for FY2025, 23.41% down from the prior year.
  • Capital Expenditures was $5663.0 for Q1 2026 at bioAffinity Technologies, up from $1.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $50786.0 in Q1 2025 and troughed at -$13442.0 in Q4 2023.
  • The 4-year median for Capital Expenditures is $5663.0 (2026), against an average of $12939.7.
  • Year-over-year, Capital Expenditures surged 5468.05% in 2024 and then plummeted 138.75% in 2025.
  • A 4-year view of Capital Expenditures shows it stood at -$13442.0 in 2023, then skyrocketed by 100.01% to $1.0 in 2024, then changed by 0.0% to $1.0 in 2025, then surged by 566200.0% to $5663.0 in 2026.
  • Per Business Quant, the three most recent readings for BIAF's Capital Expenditures are $5663.0 (Q1 2026), $1.0 (Q4 2025), and -$3646.0 (Q3 2025).